What Researchers Did
Researchers investigated the short- and long-term effects of single or repetitive hyperbaric oxygen (HBO2) exposure on neutrophil respiratory burst and phagocytosis in 40 healthy volunteers.
What They Found
In 40 healthy volunteers, no significant differences were observed in neutrophil respiratory burst or phagocytic activity before and after hyperbaric oxygen (HBO2) exposure. This was consistent across both short-term and long-term exposures, where participants received HBO2 at 2.5 atmospheres absolute for 90 minutes.
What This Means for Canadian Patients
Canadian patients undergoing hyperbaric oxygen therapy can be reassured that this treatment does not appear to negatively impact key immune functions like neutrophil respiratory burst or phagocytosis. This suggests that the innate host defense system remains intact, which is important for fighting infections during and after HBO2 treatment.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian participants or researchers.
Study Limitations
The study was conducted on healthy volunteers, which may limit the generalizability of these findings to patients with pre-existing medical conditions or compromised immune systems.